ArticleOdontology2026
Plaque disclosing agent as a guide in biofilm removal in patients with fixed orthodontic appliance: a randomized clinical trial.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05428189 (Efficacy of the Disclosing Plaque Agent as a Guide to Remove the Oral Biofilm in Orthodontic Patients), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy of the Disclosing Plaque Agent as a Guide to Remove the Oral Biofilm in Orthodontic Patients: a Randomised Controlled Trial Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective professional plaque removal is of major importance in the prevention of white spot lesions and gingivitis in patients with fixed orthodontic appliances. However, visual identification of plaque can be difficult, especially around brackets, ligatures and wires. The purpose of the present randomized clinical trial was to evaluate the effectiveness of a plaque disclosing agent (PDA) as a visual guide for biofilm removal. Thirty-two systematically and periodontally healthy adults with fixed orthodontic appliances and Plaque Index (PI) > = 25% were enrolled from October 2020 to May 2022, the subjects were equally randomized into test and control group. Primary outcome was the change in the difference in percentage of residual plaque area (RPA) between the two study groups. In the test group, a PDA was applied before professional oral hygiene, whilst the control group received a hygiene session without disclosing. The PDA was then re-applied at the end of the treatment in both groups, and the RPA was assessed via Image-J software analysis of standardized frontal photos and compared between groups. The average RPA in the test group was 3.9% (CI 95% 2.6%; 5.1%), which resulted significantly lower than in the control group, where it reached 12.0% (CI 95% 8.0%-16.0%) (p-value < 0.001). The percentage of area with residual plaque was modelled using a beta-regression model. The use of plaque disclosing agents as guidance for professional oral hygiene treatment leads to improved plaque removal in patients with fixed orthodontic appliances. NCT05428189, 2022-06-08, retrospectively registered.
Indexed as
Identifiers
42012718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.